StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.38+0.10 (+1.37%)

Close on Nov 18, 2026Market cap $1.92BP/E –Yield –

Maravai LifeSciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Maravai LifeSciences's market cap was $1.12B on Nov 11, 2026, against $519.64M a year earlier. Over the last 5 years it ranged from $278.57M to $10.07B, with a median of $1.12B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.12B+141.1%
2025Dec 31, 2025$466.52M-36.8%
2024Dec 31, 2024$738.30M-30.7%
2023Dec 29, 2023$1.07B-66.9%
2022Dec 30, 2022$3.22B-63.6%
2021Jan 29, 2021$8.85B+24.2%
2020Dec 31, 2020$7.12B–

More Maravai LifeSciences figures

See a number that looks wrong?